![OncLive](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/836/normal/Screen_Shot_2017-10-24_at_17.05.10.png?1508861154)
FCS Co-authored Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung Cancer
OncLive,
Lowell L. Hart, MD, FACP Florida Cancer Specialists
Lowell L. Hart, MD, FACP Florida Cancer Specialists
“This review provides important evidence of the broad benefit of trilaciclib utilization among patients with ES-SCLC to support…
FORT MYERS, Fla., July 31, 2023. Florida Cancer Specialists
Data confirms findings of FCS clinical research Fort Myers, Fla., July 31, 2023 – Florida Cancer Specialists